FDA Approves New Formulation of Gvoke for Severe Hypoglycemia
The FDA has approved the new Gvoke® Kit formulation for the treatment of severe hypoglycemia in patients with diabetes 2 years of age and older.
Hypoglycemia
Insulin Strategies for Managing Glycemia With Dietary Fat and Protein in Type 1 Diabetes
Investigators studied whether adjusting insulin dose and timing for people with type 1 diabetes before certain meals could improve glycemic control.
In Pediatric Type 1 Diabetes, Continuous SQ Insulin Infusions Do Not Lower HbA1c More Than MDI
Study authors conducted a retrospective cohort study to compare CSII and MDI treatments on metabolic control, body mass index, and prevalence of severe hypoglycemia in children.
With Type 1 Diabetes, Cognition Declines With Aging, Lack of Control of Glycemia and BP
The researchers hypothesized that as the participants became older adults, their cognitive functioning would decline more steeply relative to earlier assessments.
Zegalogue Now Available for Severe Hypoglycemia
The product should be stored in a refrigerator but can be kept at room temperature for up to 12 months.
Placement on New ISF-Based Scales Helps Achieve Blood Glucose Targets
This retrospective cohort study assessed hospitalized patients with diabetes to see if the new ISF-based scales improved glycemic control vs a traditional single sliding scale.
Dasiglucagon Rapidly Restores Plasma Glucose in Children With Insulin-Induced Hypoglycemia
The researchers’ objective was to evaluate the safety and efficacy of dasiglucagon in patients aged 6 to 17 years with type 1 diabetes.
Continuous Glucose Monitoring Reduces Time Preterm Infants Spend in Severe Hypoglycemia, Hyperglycemia
An international team of investigators sought to assess outcomes with real-time continuous glucose monitoring to manage glycemic control in preterm infants.
Tubeless Insulin Pump Therapy Leads to Greater Reductions in HbA1c
Previous studies have shown that continuous subcutaneous insulin infusions can lead to improvements in clinical and quality of life benefits as compared to multiple daily injections of insulin. In this study, researchers led by Sanjeev Mehta, MD, MPH, of the Joslin Diabetes Center at Harvard University, test that concept in type 1 diabetes patients.
Beginning Long-Acting Insulin Analog Resulted in Fewer Instances of Severe Hypoglycemia Than NPH Insulin
Study authors examined the risk of ED visits or hospitalizations for hypoglycemia among patients older than 65 who were initiated on glargine, detemir, or NPH insulin.
- Loading...
Loading...
Next post in Diabetes
Loading... 
Loading...